SS Innovations International (NASDAQ: SSII) has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards, an honor that recognizes a company demonstrating excellence in innovation, commercial success, industry leadership and positive societal impact. The award reflects the growing adoption of the company's SSi Mantra surgical robotic system, which is gaining traction for its advanced technology, user-friendly design, training capabilities and cost efficiency.
According to the company, as of June 22, 2026, 11,719 multi-specialty procedures have been performed using the SSi Mantra system, including 612 cardiac procedures, 175 telesurgeries and 212 pediatric surgeries. Approximately 2,100 physicians have been trained on the platform, which has been used for more than 170 procedure types and has received regulatory approval in 14 countries. The company believes these metrics underscore its growing global footprint and the system's ability to address diverse surgical needs.
The SSi Mantra system is designed to make robotic surgery more affordable and accessible, aligning with the company's vision to expand the benefits of such technology to a larger segment of the global population. SS Innovations, an American company headquartered in India, also offers a suite of SSi Mudra surgical instruments that support a variety of procedures, including cardiac surgery. The company plans to continue expanding its global presence with its cost-effective solutions.
This recognition comes amid a broader trend in the surgical robotics market, where cost and training remain key barriers to adoption. SS Innovations' focus on user-friendly design and comprehensive training programs positions it as a competitive player. The full press release can be viewed at https://ibn.fm/XWdRe.
SS Innovations International, Inc. develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible globally. The company’s product range includes its proprietary SSi Mantra surgical robotic system and its comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. For more information and updates, visit the Company’s website at ssinnovations.com.
This announcement is significant as it highlights the rapid adoption of the SSi Mantra system, which could signal a shift in the surgical robotics landscape toward more cost-effective and accessible platforms. The award and the procedural data suggest that SS Innovations is gaining momentum in a market traditionally dominated by more expensive systems.
